Qynapse Revenue and Competitors
Estimated Revenue & Valuation
- Qynapse's estimated annual revenue is currently $2.5M per year.
- Qynapse's estimated revenue per employee is $98,000
Employee Data
- Qynapse has 25 Employees.
- Qynapse grew their employee count by 9% last year.
Qynapse's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Product and Technical Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Director R&D Imaging | Reveal Email/Phone |
5 | Quality and Regulatory Affairs Director | Reveal Email/Phone |
6 | Product Manager | Reveal Email/Phone |
7 | Full Stack Engineer | Reveal Email/Phone |
8 | Architecte cloud | Reveal Email/Phone |
9 | Operations Lead | Reveal Email/Phone |
10 | AI Engineer (medical imaging) | Reveal Email/Phone |
Qynapse Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $21.6M | 140 | 28% | N/A | N/A |
#2 | $4.5M | 40 | -25% | N/A | N/A |
#3 | $18.8M | 134 | -1% | N/A | N/A |
#4 | $4.3M | 40 | 5% | $15.5M | N/A |
#5 | $19.2M | 137 | -7% | $34.5M | N/A |
#6 | $7.8M | 62 | -11% | N/A | N/A |
#7 | $17.5M | 125 | 20% | N/A | N/A |
#8 | $4.7M | 42 | N/A | N/A | N/A |
#9 | $1.5M | 18 | N/A | N/A | N/A |
#10 | $1.1M | 13 | N/A | N/A | N/A |
What Is Qynapse?
Qynapse is a medical technology company that provides a cloud-based platform for the diagnosis, prognosis and drug efficacy measurement for central nervous system diseases (such as multiple sclerosis, Alzheimer's, Parkinson's and ischemic stroke). Qynapse is a spin-off of the CATI consortium of neuroimaging research laboratories and is headquartered in Paris.
keywords:N/AN/A
Total Funding
25
Number of Employees
$2.5M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.7M | 25 | 0% | N/A |
#2 | $2.5M | 25 | N/A | N/A |
#3 | $2.5M | 25 | N/A | N/A |
#4 | $2.5M | 25 | N/A | N/A |
#5 | $2.5M | 25 | -4% | N/A |